Ependymoma, Recurrent Active Not Recruiting Phase 2 Trials for Irinotecan (DB00762)

Also known as: Ependymoma Recurrent / Recurrent Ependymoma

IndicationStatusPhase
DBCOND0106575 (Ependymoma, Recurrent)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04743661131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaTreatment